Your Article Summary
See Latest ArticlesManufacturing a rapid biologic response
Drug Development Research, 06/19/09
Latham PW - Unfortunately, this kind of stockpiling is very expensive, and does not provide protection against novel threats. Fortunately, there currently exist many new technologies that, when combined strategically, have the potential to significantly reduce the time and cost associated with the PD and manufacturing of biologic countermeasures.
Today in Research & Development...keeping you current
Receive free subspecialty "5-minute updates" via email
deCODE Discovers A Major Risk Factor for Type 2 Diabetes Dependent on Parent of Origin
deCODE genetics, 12/17/09
The Medtronic Foundation Offers Grants to Schools Participating in Online Sudden Cardiac Arrest Response Training
Medtronic, 12/17/09
AstraZeneca and the University of Virginia sign strategic research collaboration to develop novel treatments for cardiovascular disease
AstraZeneca, 12/16/09